chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Diarrhea; aches/tummy ache; sick; Fever; This is a spontaneous report from a contactable consumer (patient mother). A 17-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration, administered in Arm Right on 14May2021 as dose 1, single for COVID-19 immunisation. The patient medical history was not reported. There were no concomitant medications. Patient did not receive any other prior Vaccinations (within 4 weeks). On 16May2021, the next day after the 15th patient experienced Diarrhea and patient felt sick between the 15th to the 20th. Patiet had a reaction for 4 days. It was 5 days with diarrhea and tummy. Then it went away. Treatment: Just diet and staying home. On 15May2021, The next day after vaccination patient experienced Fever. It was going away 5 days later. Patient received Gatorade and Tylenol for fever and aches. Any AE(s) did not require a visit to Emergency Room and Physician Office. Patient received second shot on 05Jun2021. The outcome of events was recovered on 20May2021.  Information on Lot/Batch number has been requested.
Dizziness, breathing problems, chest discomfort with pressure (not pain) just pressure on the left side around my heart, tightness, heart racing, feeling totally different than normal. Headache and fatigue with no energy at all. I have pain down my back right down the spinal column. Weakness all over. No strength. I have tingling into my legs and feet. Odd sensations. It has been more than a week and it is not getting better. Dizzy and feverish but I have no fever. I test daily for covid 19 and always negative. Tested for flu, it was negative.
Site: Pain at Injection Site-Mild, Systemic: Fainting / Unresponsive-Medium, Systemic: Flushed / Sweating-Medium, Additional Details: as patient was leaving the store after approx 15 minutes post vaccine she stepped outside and fell down with dizziness, emts called, she didnt need to go with them. she is recovered.
Events occurred on 10/19/11: 9:15 am - received flu shot. 1:15 pm - eyes (red, itchy, watery). 1:30 pm - tongue swelling, throat itchy/scratchy and had chills, eyes still red/watery. 1:45 pm - took BENADRYL. 2:30 pm - tongue still swollen but not worse, felt achy with chills red/watery eyes. 4:45 pm - arrived at home took THERAFLU, headache began. 6:00 pm - swelling of tongue better still had headache. Thursday - felt better.
vertigo; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (vertigo) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VERTIGO (vertigo). At the time of the report, VERTIGO (vertigo) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Information has been received from a registered nurse concerning a 17 year old male with no pertinent medical history and with no known drug reaction or allergies who on 13-JUN-2012 was vaccinated intramuscularly with the first 0.5ml dose of GARDASIL (Lot# 666162/0565Z, expired date 15-SEP-2012). Concomitant therapy included PAXIL. On 13-JUN-2012 20 minutes after injection the patient complained of stinging but also later experienced numbness and a tingling feeling from elbow to the upper arm region in the same area of the injection site. The patient was seen in the office for medical attention. There was no lab diagnostics studies performed. No treatment was given. At the time of this report the patient had not recovered. Follow-up information was received from a registered nurse concerning a 17 year old male student with no illness at time of vaccination and no pre-existing allergies or medical conditions who on 13-JUN-2012 at 09:55 AM, was vaccinated intramuscularly with the first 0.5ml dose of GARDASIL in right deltoid. No other co-suspects were reported. It was reported that on 13-JUN-2012 at 09:55 the patient experienced numbness and tingling of right arm. The patient did not seek medical attention. On 13-JUN-2012, the patient recovered from numbness and tingling of right arm. The relatedness for the patient's events was not provided for GARDASIL. This is one of several reports received from a same source. Additional information is not expected.
Light headed and reports a feeling of motion sickness describes it as a wave that starts from abdomen up to chest area.  Later in the day patient reports a feeling of being lost/confused, tiredness and still has motion disturbance.
Flu vaccine administered 10/17/03.  Next day pt developed fever, nausea, vomiting.  Mom took to MD on 10/23/03.  MD did blood test and throat culture.  MD stated to mom that he thought symptoms were probably from flu shot.
Patient received Moderna Covid -19 vaccine but was not 18 years of age. She was 17 years old (birth date 01/19/2004)
Patient c/o feeling dizzy, and lightheaded while on 30 min observation. Patient escorted with wheelchair to private patient assessment area. Patient assisted onto bed, vitals taken @ 0908. BP : 150/75  HR: 80  O2: 98% on room air. Patient denies SOB. MD notified. Dr. (Name) assessed patient and stated" give her water and snack,and monitor for additional 15 minutes, then I will reassess in few minutes. Patient given water, tolerated well. During post reaction monitor in private area, patient states" my chest feels really tight and heavy, and I have a history of bypass it feels the same". MD notified. Patient reassessed by Dr. (Name), and MD states" call 911 and have patient transported to ER for further eval and care" called 911, report given to paramedic, patient transported via fire dept to ER in stable condition.
pain in hands and at the base of thumbs; pain in right hamstring and calf muscles, then moved to left hamstring and calf muscles; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732), via an unspecified route of administration in the arm left on 24Mar2021 at 17:30 (at the age of 59-year-old), as a single dose for COVID-19 immunisation. Medical history included depression and obesity on unknown dates. Concomitant medications included citalopram (MANUFACTURER UNKNOWN), omeprazole (PROTONIX) and ascorbic acid, biotin, boron, calcium, calcium pantothenate, chlorine, chromium, cholecalciferol, copper, cyanocobalamin, folic acid, iodine, magnesium, manganese, molybdenum, nickel, nicotinamide, phosphorus, phytomenadione, potassium, pyridoxine hydrochloride, retinol, riboflavin, selenium, silicon dioxide, thiamine hydrochloride, tocopherol, vanadium, zinc (CENTRUM SILVER) from an unknown dates taken for an unknown indications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient previously took codeine (MANUFACTURER UNKNOWN) for an unknown indication on unknown dates. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021, the patient experienced pain in right hamstring and calf muscles, then moved to left hamstring and calf muscles (muscle pain) and also the patient experienced pain in hands and at the base of thumbs (pain in extremity). The adverse events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events (pain in right hamstring and calf muscles, then moved to left hamstring and calf muscles and pain in hands and at the base of thumbs) and included treatment with X-rays, physical therapy (PT) and unspecified medications on unknown dates. The clinical outcome of the events pain in hands and at the base of thumbs and pain in right hamstring and calf muscles, then moved to left hamstring and calf muscles was not recovered.   No follow-up attempts are needed. No further information is expected.
Nausea, Dizziness, stomach cramps,  feelings of stabs in body mainly legs, minor chest pains,  headache, fever, joint pain, body shakes
Information has been received from a licensed practical nurse concerning a 44 year old male, with no pertinent medical history, drug reactions or allergies, who on 31-JAN-2007 was vaccinated with 10mcg, his first dose RECOMBIVAX HB. There was no concomitant medication. On 31-JAN-2007 the patient experienced pain, redness and swelling at injection site (Lot # 655810/1160F). On 05-MAR-2007 the patient received a second dose of RECOMBIVAX HB, (Lot # 655810/1160F) that may have been improperly stored. No reaction was reported with this vaccination. Unspecified medical attention was sought. There were no lab diagnostic studies performed. The patient was considered recovered at the time of this report. There was no product quality complaint. Additional information has been requested.
This case was reported by a physician and described the occurrence of lethargy in a patient who received diphtheria and tetanus toxoids and acellular pertussis vaccine absorbed for prophylaxis. The patient's medical history, concurrent conditions, and concurrent medications were not reported. On an unspecified date, the patient received Infanrix. At an unknown time post immunization, the patient experienced lethargy, fever of 101 to 102 degrees F, and an injection site reaction characterized by swelling, redness, and itching. The patient was seen by the physician who prescribed cold compress, paracetamol and applications of ice. The events were unresolved as of 5/23/03. The reporting physician considered the events were probably related to vaccination with Infanrix lot DTPA574A2. Comment: The reporter indicated that three children experienced these events after receiving Infanrix lot DTPA574A2. However, they are not presently identifiable.
Hospitalized (10.24.21 - currently still admitted);  COVID-19 positive;  fully vaccinated  HISTORY OF PRESENT ILLNESS: Patient is a 52 y.o. male who presents today with shortness of breath, cough and fever. The patient has a history of diabetes, HTN, GERD. He started to feel like he was getting a mild cold on 10/18 with congestion, runny nose, chills and a mild cough. The next day he had worsening cough and fever and came to the ER. He was diagnosed with COVID and sent home with cough medicine and an albuterol inhaler. He continued to have worsening cough, his PCP gave him prednisone and a Zpack. He has a pulse ox on his watch and today it started dropping into the 80s so he came to the ER for evaluation. The patient is fully vaccinated for COVID. He was scheduled to have monoclonal antibodies tomorrow. In the ER the patient was febrile, hypoxic and found to have hypokalemia. He had a normal d dimer. CXR showed covid pneumonia. He was started on dexamethasone and supplemental oxygen. The hospitalist team was contacted for further management * Pneumonia due to COVID-19 virus Assessment & Plan Fully vaccinated  Symptoms began 10/19, tested positive 10/20 Requiring 2L NC Start dexamethasone, remdesivir  Monitor CRP, CMP, CBC, d dimer Procal elevated, will start antibiotics for superimposed bacteria infection. Was already on azithro outpatient, continue this and add rocephin Supportive care Wean oxygen as tolerated Lovenox for DVT prophylaxis  Progress Note 11.1.21: Acute respiratory failure with hypoxia Assessment & Plan  high-flow nasal cannula now weaned to 6 l nc, clinically feels and looks improved   ddimer, crp, lft stable   Continue dvt prophylaxis with lovenox , repeat imaging prn with clinical changes , currently improving oxygenation needs -continue with supplemental oxygen for now, goal oxygen saturation greater than 92% * Pneumonia due to COVID-19 virus Assessment & Plan -symptom onset 10/18 -presented requiring 2 L of oxygen,  weaned to  Hfnc at 45 / 45  Now 6 l nc   -still on dexamethasone, now day 9 of 10 -completed remdesivir 5 of 5 -procalcitonin was elevated, completed a course of azithromycin and x6 day  Ceftriaxone day x 6  cxr 10/28  with Interval worsening of bilateral airspace opacities, consistent with worsening COVID 19 pneumonia.  -continue to encourage prone positioning   Clinically improving , afebrile , >10 day onset ss can dc severe respiratory isolation
pt recvd vax & devel local redness & pain; tenderness around inject site; t 102; pt had n & v & lethargy;
Syncope fall from table bite to his tongue. Provider at patients side vitals taken cool compress provided and vitals stable at discharge 11:15Am.
I developed a DVT in my left leg on 04/08/21 and had to have an IVC filter placed on 04/13/21. I have had several DVTs since getting the vaccine. I have been hospitalized on 04/08/21 to 04/09/21 and from 04/25/21 to 05/01/2021 with DVT and kidneys not working. Now have long term health complications and permanent damage to right leg.
Back Spasms (ongoing).  Makes me wonder about blood clots as my back was the first thing to hurt when I had a PE.
Day 2 I had severe shoulder blade, neck and chest pains. Day 4 I had a red swollen rash on the left area of the vaccine. Day 7 my left clavicle area became swollen. Very tired all the days!
Caring for my wife who was COVID-19 positive and I began feeling poorly on 11/3. Symptoms were aches, pains, fatigue, respiratory difficulties, and trouble sleeping. Tested positive for COIVD-19 on 11/4 and was prescribed Paxlovid. Symptoms began resolving over the next couple days. Had one day of feeling better and then began experiencing rebound symptoms.  Rebound symptoms were aches, pains, fatigue, respiratory difficulties, and trouble sleeping. Also began having swelling of eyelid and swelling around my eye. Went to doctor and she said she thought it was cellulitis. Prescribed augmentin for 7 days and symptoms of eye issues began resolving quickly. Experienced GI sensitivity at end of course of Augmentin but have never previously had issues with Augmentin. Symptoms and fatigue have greatly improved still experiencing lingering cough. Was taking flonase early on during my COVID-19 infection and seemed to have less severe symptoms than my wife who was sick at the same time.  Arthritis symptoms have resolved since COVID-19 infection and subsequent taking of Paxlovid and arthritis has not returned.
At 11:55 pm the day of my Covid Booster, I woke with tachycardia, feeling of nausea. I checked my heart rate and it was 116-120 and remained that for a few hours. I felt weak and drank water and continued to try and rest but the fast heart rate lasted for 2-3 hours. Nausea eventually subsided as well. Next morning heart rate was normal. Never developed temperature.
Pt received covid vaccine and felt light-headed, fatigue, and a headache. Pt monitored for 30 minutes by EMS and BP was dropping down to 90/62 from 118/80. Pt refused transport.
11-7-08 Got the flu shot approximately 6:20pm.  11-8-08 approximately 8pm got fever and chills.  11-9-08 - Fever, chills, couldn't get out of bed-no pain- just very tired, needed to lay down.  Got rash from neck down to past waist and down arms.  11-12-08 went to my doctor with rash and fever and was told I had an allergic reaction to the flu shot.  I was given PREDNISONE and the rash went away in 3 days.
14 cm x 8 cm swollen, erythematous lesion on (R) upper thigh - warm to touch.
this is 1 of 2 pt from this site to devel an inj site rxn characterized by erythema, swelling & discomfort p/vax;
Patient given flucelvax in left deltoid and pneumovax 23 in right deltoid. Patient reported waking up on 10/27/19 with right shoulder joint stiffness and limited arm mobility along with overall cold chills. Patient called to report reaction to pharmacy on 10/28/19 at 1015AM. Patient stated some relief from the intensity of reaction when waking upon 10/28/19.  Patient directed to take NSAIDS OTC therapy and report back to pharmacy and/or physician if mobility or cold chills do not improve or worsen within 48 hours. Patient PCP office notified. Left message with employee to update patient data.
Pt given a Pfizer booster  2 times within 5 days, in error.  #3 Pfizer vaccine given 10/7/21, and 4th given 1012/21
?COVID arm? - red circular area around injection site that is still growing (I woke up the next day after vaccine and had it, it is now 2 days later and it is still growing), warm to touch, very sore to touch and to move arm Other symptoms: Body aches, headache, dizziness, night sweats and chills (but with no fever)
10/08/2021 within the 1st 2 minutes tingling in my tongue, within 20 minutes I had to clear my throat, I felt like something was stuck in my throat. In the evening it was hard to swallow food. I had no trouble breathing. At 10:30 pm, I had shortness of breath, and tightness in my chest, that lasted 45 minutes or so to an hour then it went away. I had a little arm soreness. On day 3, I had gastrointestinal problems, like diarrhea. And a severe headache on day 3 and 4. The next morning 07:00 am, I had the shortness of breath and chest tightness and that lasted another hour or so.  Throughout the day I was fine. Ever since then I feel like I have a shortness of breath.  Last week I had like a burning in my chest, like heart burn, I get that intermittently, at least once a day I get shortness of breath. I called my nurse practitioner in my allergist office, she had me start on a steroid inhaler Qvar. I also started a medicine for reflux prevacid. I have been following up with the nurse practitioner they are thinking of putting me on a stronger inhaler. I was supposed to get my 2nd injection on 11/05/2021. They don't want me to get the 2nd dose until my asthma is under control. My primary care physician is not advising me to get the 2nd dose currently.
mild arm soreness; nausea; chills; fever; headache; fatigue; Aching; This is a spontaneous report from a contactable other healthcare professional (patient). A 43-years-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, lot number: EL9810, patient was 43-year-old at the time of vaccination), via intramuscular route of administration, administered in Arm Left on 09Feb2021 at 08:30 AM as DOSE 2, SINGLE for covid-19 immunisation. Medical history included depression, anxiety. No other vaccine received in four weeks. Concomitant medication(s) included lamotrigine (LAMICTAL); fluoxetine hydrochloride (PROZAC); monascus purpureus (RED YEAST RICE); curcuma longa (TURMERIC [CURCUMA LONGA]); boswellia serrata (BOSWELLIA); chondroitin sulfate, glucosamine (GLUCOSAMINE CHONDROITIN [CHONDROITIN SULFATE; GLUCOSAMINE]); vitamin d3 (VITAMIN D3); chromium picolinate (CHROMIUM PICOLINATE) all were taken for an unspecified indication, within two weeks of vaccination, start and stop date were not reported. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, lot number: EL1283, patient was 43-year-old at the time of vaccination), via intramuscular route of administration, administered in Arm Left on 19Jan2021 at 09:00 AM as DOSE 1, SINGLE for covid-19 immunisation and experienced only Arm soreness. No covid prior vaccination, no covid tested post vaccination, no known allergies reported. On 09Feb2021 at 04 PM, the patient experienced mild arm soreness, nausea, chills, fever, headache, fatigue, aching. Patient did not receive treatment for events. The outcomes of events were recovering.  Follow-up (12May2021): Follow-up attempts completed. No further information expected.
approx 10 mins p/shot pt became diaphoretic, weak, w/c/o tingling in neck & face & tightness in chest; pt was given DPH;
On Friday, May 18, 2007 the child received a varicella and a Tdap vaccination at our public health clinic.  Child's mother did not report any immunocompromising conditions or other contraindications to vaccination at that time.  The mother reports that on Sunday, June 3, 2007 she noticed spots on the child's chest and back.  She thought they were mosquito bites.  On Monday more spots developed and the child was complaining that they itched.  The mother called her family physician who said they thought it was chickenpox and to report to the health dept where he was vaccinated.  Mother reports child had mild fever of 99.8 F and was fatiqued.  Child has approximately 24-25 lesions on chest, back, arms, and legs.  Mother denied him having any exposure to someone with chickenpox.  She reports he is a healthy child, does not have any medical conditions and that he is not taking any medications.  Reports that lesions are beginning to crust over and the last new lesions appeared on Tuesday, June 5, 2007.  Mother did not take child to visit doctor.
Difficulty breathing,shortness of breath; Coughing; Couldn't sleep; Chest full of congestion; This spontaneous case was reported by a non-health professional and describes the occurrence of DYSPNOEA (Difficulty breathing,shortness of breath), COUGH (Coughing), INSOMNIA (Couldn't sleep) and CHEST DISCOMFORT (Chest full of congestion) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L20A and 039A20A) for COVID-19 vaccination.     No Medical History information was reported.   On 28-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (Difficulty breathing,shortness of breath), COUGH (Coughing), INSOMNIA (Couldn't sleep) and CHEST DISCOMFORT (Chest full of congestion). At the time of the report, DYSPNOEA (Difficulty breathing,shortness of breath), COUGH (Coughing), INSOMNIA (Couldn't sleep) and CHEST DISCOMFORT (Chest full of congestion) outcome was unknown. Not Provided          Treatment provided included steroid inhaler and antibiotics. Concomitant medication list was not provided. Action taken with mRNA-1273 in response to the event was not applicable.
Pt with pain at injection site since injection, never resolved, has exacerbations of pain last approx. one week at a time. Hurts with some movement and lay on it. 2/20/04 first visit-given course Cerebrex 200mg x 14 days denied redness at site, swelling, fever. Denies numbness, weakness, electric like sensations.
2nd Pfizer given 2/1/2021 lot# EN9581, IM, left deltoid 3rd Pfizer dose given 10/04/2021, IM, right deltoid Patient states that issue began in the middle of June when left collar bone dislocated, states that lymph nodes in that area were swollen.  Took Naproxen with some relief but continues to have limited use of shoulder.  States certain motions of arm and shoulder will cause left collar bone to come "out of socket."  He also continues to  have soreness from "inflamed lymph nodes" in the left shoulder area.
This spontaneous report as received from a pharmacist, who was also thepatient, via a company representative refers to a male patient of unknown age. The patein's medical history, concurrent conditions and concomitant therapies were not reported. On 20-MAY-2016, the patient was vaccinated with ZOSTAVAX  (lot # L031274) (route of administrtaion and expiry date were not reported).  Other suspect therapies included sterile diluent (manufacturer unknown) (dose and route of administrtaion not repored). However, it was reported that, the company representative did not have information if sterile diluent (manufacturer unknown) was used fr reconstitution. Since 20-MAY-2016, reported as "sinec avccine administration", the patient was having right shoulder muscle pain and muscle problems. The outcome of right shoulder muscle pain and muscle problems was reported as not recovered. Rlatedness between right shoulder muscle pain and muscle problems ans the vaccination with ZOSTAVAX and sterile diluent (manufacturer unknown) as not reported. Additional information has been requested.